Therapeutic doses of efzofitimod significantly improve multiple pulmonary sarcoidosis efficacy measures - Milan 2023

Sarcoidosis: challenges in disease assessment and management of complications

Chair(s): Paolo Spagnolo, Dominique Israel-Biet

Session type: Poster session

Therapeutic doses of efzofitimod significantly improve multiple pulmonary sarcoidosis efficacy measures

Nelson Kinnersley

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Lung Texture Analysis to phenotype Sarcoidosis

Andrew Mccorkell

Poster

Abstract

Prevalence and evolution of airway obstruction in sarcoidosis

Gianmarco Gasparini

Poster

Abstract

Long-term effectiveness of infliximab treatment in refractory sarcoidosis

Angela Mikaczo

Poster

Abstract

Serum D-dimer levels as an activity marker in sarcoidosis

Halil Yanardag

Poster

Abstract

Prevalence of comorbidities in patients with sarcoidosis: a single center study

Lorena Gallotti

Poster

Abstract

Prevalence of cardiac involvement in a cohort of patients with Sarcoidosis

Lorena Gallotti

Poster

Abstract

Sarcoidosis and Obstructive Sleep Apnoea: CPAP's impact on daytime sleepiness and fatigue

Lorena Gallotti

Poster

Abstract

Clinical characterisation of thoracic sarcoidosis in Spain

Joel Francesqui

Poster

Abstract

Clinical and radiological presentation of patients treated for sarcoidosis

Nicol Bernardinello

Poster

Abstract

Therapeutic doses of efzofitimod significantly improve multiple pulmonary sarcoidosis efficacy measures

Nelson Kinnersley

Poster

Abstract

Evaluation of bone mineral density and fracture risk in sarcoidosis population

Paolo Cameli

Poster

Abstract

SARCOIDOSIS AND EMERGENCY HOSPITALIZATION : CAUSES AND PROGNOSIS

Pierre Gazengel

Poster

Abstract

Cardiac and brain involvement in Sarcoidosis, Data from the Austrian registry

Claudia Guttmann-ducke

Abstract

Characteristics of sarcoidosis patients admitted to hospital one center experience

Karol Baczek

Poster

Abstract

Pulmonary rehabilitation in sarcoidosis: a systematic review and meta-analysis

Estrella Caballeria Lamelas

Poster

Abstract

Prevalence of refractory pulmonary sarcoidosis in Ukraine

Ievgeniia Merenkova

Poster

Abstract

Multicenter, randomized, double-blind, phase 2 study to assess the efficacy and safety of OATD-01, an oral inhibitor of chitinase-1 for the treatment of active pulmonary sarcoidosis.

Zbigniew Zaslona

Poster

Abstract

Monitoring thoracic sarcoidosis with cardiopulmonary exercise test and spirometry, their insights to nuclear imaging inflammatory activity

Chiara Torregiani

Poster

Abstract

Survival in sarcoidosis 11 years of observation of 2625 patients.

Piotr Boros

Poster

Abstract

Severe sarcoidosis: Management and prognosis

Soumaya Ben Saad

Poster

Abstract

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}